When (if ever) might you recommend adjuvant prostate fossa RT in a high risk patient with bone metastases?

For example, gross residual disease and a PSA that never became undetectable. Is it reasonable to hope that systemic therapy alone (ADT +/- chemotherapy) might prevent a symptomatic local recurrence? Or would it be prudent to wait and treat the prostate fossa only if it becomes symptomatic?